Trial Details

Not Recruiting
Basic Information
Clinical ID c3157
Identifier NL-OMON44981
Trial Title A MULTICENTER OPEN-LABEL EXTENSION STUDY TO ASSESS LONG-TERM SAFETY OF PF-00547659 IN SUBJECTS WITH ULCERATIVE COLITIS (TURANDOT II) - TURANDOT II
Trial URL Visit Original Page
Study Information
Study Results

No results available
Conditions inflammatory bowel disease Ulcerative colitis;10017969
Interventions Subjects will be administered one or more SC doses of the study drug at day 1 (baseline) and then every 4 weeks during the treatment period.
Participant Information
Sponsor Shire
City -
Country/Region Netherlands
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement ADULT, ELDER, OLDER_ADULT
Study Design
Study Type Interventional
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -